If the crosstalk between p96ABL/BCR and p185BCR/ABL leads to an increased kinase activity, in a reverse conclusion the down-regulation of p96ABL/BCR should increase the responsiveness of Ph+ ALL cells towards selective ABL-kinase inhibitors. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.